Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Verano HoldingsNEOE:VRNO 80 OCF Yield % is 12.53 as of Jul. 21, 2026, which is 53% above its 10-year median of 8.21. GuruFocus rates NEOE:VRNO with a GF Score™ of 80/100 and a GF Value™ of C$11.27 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Verano Holdings ranks better than 84.98% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Verano Holdings OCF Yield % Related Terms
Verano Holdings OCF Yield % Historical Data
* Premium members only.
The historical data trend for Verano Holdings's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Verano Holdings's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Verano Holdings OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Verano Holdings's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Verano Holdings's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Verano Holdings (NEOE:VRNO) has a OCF Yield % of 12.53 as of Jul. 21, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Verano Holdings and its competitors. This is 53% above median its historical median of 8.21. Over the past decade, Verano Holdings' OCF Yield % has ranged from 0.31 to 70.04. According to the industry distribution chart, Verano Holdings ranks #151 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 15%.
Is Verano Holdings' OCF Yield % too high?
Verano Holdings' current OCF Yield % of 12.53 is 53% above median its 10-year median of 8.21. Over the past 10 years, this metric has ranged from a low of 0.31 to a high of 70.04. The Drug Manufacturers industry median OCF Yield % is 3.62. Verano Holdings' value of 12.53 is 246.1% above this industry median. Based on the distribution chart, Verano Holdings ranks #151 out of 1005 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Verano Holdings has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Verano Holdings' OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Verano Holdings ranks #151 out of 1005 companies for OCF Yield %. This places Verano Holdings in the top 15% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 3.62. Verano Holdings' value of 12.53 is 246.1% above this benchmark. Historically, Verano Holdings' own OCF Yield % has ranged from 0.31 to 70.04 over the past decade. While the company's 10-year median is 8.21 vs. the industry median of 3.62, Verano Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.62, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Verano Holdings's current OCF Yield % of 12.53 is 246.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Verano Holdings and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Verano Holdings's current OCF Yield % is 12.53, which is 53% above median its own 10-year median of 8.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Verano Holdings stock overvalued right now?
Based on GuruFocus' analysis, Verano Holdings (NEOE:VRNO) is currently considered Modestly Undervalued. The stock's GF Value™ is C$11.27, compared to a current price of C$8.30 — trading 26.4% below its estimated fair value. The current OCF Yield % is 12.53, which is 53% above median its 10-year median of 8.21 and 246.1% above the Drug Manufacturers industry median of 3.62. Verano Holdings' overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Verano Holdings (NEOE:VRNO), the current OCF Yield % is 12.53 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Verano Holdings (NEOE:VRNO) Overvalued in 2026?
Based on GuruFocus' analysis, Verano Holdings stock appears to be undervalued.
The current stock price of C$8.30 is trading 26.4% below its estimated GF Value™ of C$11.27.
GuruFocus considers Verano Holdings to be Modestly Undervalued.
Key valuation signals for NEOE:VRNO:
OCF Yield %: 12.53 (53% above median its 10-year median of 8.21)
GF Value™: C$11.27 vs. price of C$8.30 (26.4% below fair value)
Industry Position: 246.1% above the Drug Manufacturers median (#151 of 1005)
No single metric tells the full story. See the NEOE:VRNO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Verano Holdings Corp is a vertically integrated, multi-state cannabis operator in the United States. The company operates through cultivation (wholesale) and retail segments. Its consumer brands include Encore, Avexia, MUV, Savvy, BITS, and Verano, while its retail dispensaries operate under brands such as Zen Leaf and MUV. The company derives the majority of its revenue from the retail segment.
80GF Score
Get the complete analysis for NEOE:VRNO
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NEOE:VRNO has been successfully added to your 
